With the official shortage over, the FDA has signaled it will crack down on compounded tirzepatide, affecting patients who've relied on the lower-priced medication.
People are concerned. They're saying, 'This has been life changing but I don't have $1000 to pay out of pocket and my insurance isn't going to cover it,'" Ted Kyle stated.
The FDA's announcement on December 19 to officially remove tirzepatide from the shortage list means compounding pharmacies won't be allowed to offer most versions.
Collection
[
|
...
]